Project Grant R61DA064042
Award Date 8/1/25
Completion Date 7/31/27
Dollars Obligated $575K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
- This Project Grant award of $1,573,958 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on identifying individuals who are viremic and/or have substance use disorder (SUD) to engage them for early intervention. The project will implement routine SUD screening using the NIDA Quick Screen and a social network intervention to find individuals who are viremic, have SUD, or both, and link them to harm reduction and HIV...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $677,250 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Miami. The grant, awarded on June 15, 2025, supports the development and testing of the "Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) Intervention" for implementation in syringe service programs. The project aims to engage women with experiences of...
- The U.S. National Institutes of Health (NIH) awarded a Cooperative Agreement under the Trans-NIH Research Support program (CFDA 93.310) to Wake Forest University Health Sciences (WFUHS) in the amount of $1,098,513 beginning September 1, 2025. The overarching goal of the "CASCADE" (Carolina Addiction Science Coalition for Accelerating Discovery and Engagement) project is to investigate the impacts of drug use patterns and addiction treatment on the HIV prevention and care cascade in the...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is funded under the Drug Use and Addiction Research Programs (CFDA 93.279). The $660,104 award, with a performance period from August 15, 2025 to July 31, 2027, will be used by The University of Texas Southwestern Medical Center (UT Southwestern) to assess the impact of adding personalized contingency management via a mobile app (DynamiCare) to a patient navigator...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $3,939,754 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Northern California Institute for Research and Education, Inc. (NCIRE) for the "Stimulant and Polysubstance Use, Inflammation and Sex Effects on Myocardial Disease in HIV (SPISE)" research program. The goal of this 5-year project, beginning July 15, 2025, is to investigate the role of stimulant...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $4,725,000 to the University of California, Los Angeles (UCLA) to develop new dissemination strategies that improve the availability and user-friendliness of research on preventing HIV transmission and effectively treating substance use disorders (SUDs). The project aims to mitigate policy-level barriers and upstream barriers that hinder access...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $426,036 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Tulane University. The award will fund a study to examine the feasibility and acceptability of a virtual reality-based mindfulness intervention, called "TRIPP," to support people with comorbid HIV and substance use disorders. This population faces significant public health challenges, as substance...
- The federal Project Grant award of $1,465,275.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the role of HIV proteins in psychostimulant abuse, specifically focused on understanding how HIV and HIV viral proteins alter the molecular actions and behavioral expressions of amphetamine. The project aims to elucidate the mechanisms by which HIV infection and HIV proteins, such as Tat and gp120,...
- This $335,356 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to demonstrate the feasibility, acceptability, and validity of remote self-collection of sweat-derived biomarkers to measure inflammation in people living with HIV (PLWH), especially those who use stimulants. The study will recruit a sub-sample of 100 participants from the ongoing American Remote Collection HIV Epidemiology Study...
- This Project Grant award of $198,854 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports a study to measure social isolation, loneliness, and stigma experienced by older adults living with HIV who use methamphetamine. The research will characterize trajectories of social isolation and loneliness over 12 months, and explore patient perspectives on how...